blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2292225

EP2292225 - Dosage form comprising taxol in crystalline form [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  13.01.2020
Database last updated on 03.10.2024
Most recent event   Tooltip17.01.2020Revocation of patentpublished on 19.02.2020  [2020/08]
Applicant(s)For all designated states
BOSTON SCIENTIFIC SCIMED LIMITED
The Corporate Centre Bush Hill, Bay Street
St. Michael / BB
[2011/10]
Inventor(s)01 / Kunz, Lawrence, L.
2114 W.Dry Creek Road
Ellensburg, WA 98926 / US
02 / Klein, Richard, A.
20311 Maplewood Drive
Edmonds, WA 98026 / US
03 / Reno, John, M.
2452 Elm Drive
Brier, WA 98036 / US
 [2012/19]
Former [2011/10]01 / Kunz, Lawrence, L.
2114 W.Dry Creek Road
Ellensburg, WA 98926 / US
02 / Klein, Richard, A.
20311 Maplewood Drive
Edmonds, WA 98026 / US
03 / Reno, John, M.
2452 Elm Drive
Brier, WA 98036 / US
Representative(s)Peterreins Schley
Patent- und Rechtsanwälte PartG mbB
Hermann-Sack-Straße 3
80331 München / DE
[N/P]
Former [2012/19]Peterreins, Frank
Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Strasse 8
80807 München / DE
Former [2011/10]Peterreins, Frank
Fish & Richardson P.C. HighLight Business Towers Mies-van-der-Rohe-Strasse 8
80807 München / DE
Application number, filing date10175858.931.03.1998
[2011/10]
Priority number, dateUS1997082968531.03.1997         Original published format: US 829685
US1997082799131.03.1997         Original published format: US 827991
[2011/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2292225
Date:09.03.2011
Language:EN
[2011/10]
Type: B1 Patent specification 
No.:EP2292225
Date:09.05.2012
Language:EN
[2012/19]
Type: B9 Corrected patent specification 
No.:EP2292225
Date:27.06.2012
[2012/26]
Search report(s)(Supplementary) European search report - dispatched on:EP03.01.2011
ClassificationIPC:A61K31/335, A61L31/16, A61P7/00, A61F2/06, A61K31/16
[2011/10]
CPC:
A61K31/403 (EP,US); A61K31/00 (EP); A61K31/04 (EP);
A61K31/131 (EP); A61K31/135 (EP); A61K31/138 (EP);
A61K31/165 (EP); A61K31/17 (EP); A61K31/337 (EP);
A61K31/352 (EP); A61K31/365 (EP); A61K31/40 (EP);
A61K31/4025 (EP); A61K31/4035 (EP); A61K31/407 (EP);
A61K31/519 (EP); A61K31/551 (EP); A61K31/704 (EP);
A61K47/34 (EP); A61K47/51 (EP); A61K47/6803 (EP,US);
A61K47/6809 (EP); A61K47/6817 (EP); A61K47/6831 (EP);
A61K47/6843 (EP); A61K47/6923 (EP); A61K47/6927 (EP);
A61K9/0024 (EP); A61K9/0051 (EP); A61L31/08 (EP);
A61L31/148 (EP); A61L31/16 (EP); A61P43/00 (EP);
A61P7/00 (EP); A61P9/00 (EP); A61P9/14 (EP);
A61L2300/416 (EP); A61L2300/432 (EP); A61L2300/602 (EP);
A61L2300/606 (EP); A61L2300/622 (EP); A61L2300/63 (EP);
G01N2800/323 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2011/10]
TitleGerman:Darreichungsform enthaltend Taxol in kristalliner Form[2011/10]
English:Dosage form comprising taxol in crystalline form[2011/10]
French:Forme de dosage comprénant du taxol en forme cristalline[2011/10]
Examination procedure08.09.2010Examination requested  [2011/10]
27.01.2011Despatch of a communication from the examining division (Time limit: M04)
26.04.2011Reply to a communication from the examining division
11.07.2011Despatch of a communication from the examining division (Time limit: M02)
13.07.2011Reply to a communication from the examining division
19.09.2011Communication of intention to grant the patent
21.12.2011Fee for grant paid
21.12.2011Fee for publishing/printing paid
12.11.2014Observations by third parties
28.11.2014Observations by third parties
11.08.2016Observations by third parties
Parent application(s)   TooltipEP04023674.7  / EP1512398
EP09004768.9  / EP2098230
EP98914366.4  / EP0975340
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19980914366) is  21.08.2001
Opposition(s)Opponent(s)01  07.02.2013  12.02.2013  ADMISSIBLE
Terumo Kabushiki Kaisha
44-1, Hatagaya 2-Chome Shibuya-ku
Tokyo 151-0072 / JP
Opponent's representative
Prüfer & Partner mbB Patentanwälte · Rechtsanwälte, et al, et al
Sohnckestraße 12
81479 München / DE
 [N/P]
Former [2013/12]
Opponent(s)01  07.02.2013  12.02.2013  ADMISSIBLE
Terumo Kabushiki Kaisha
44-1, Hatagaya 2-Chome Shibuya-ku
Tokyo 151-0072 / JP
Opponent's representative
Prüfer & Partner GbR European Patent Attorneys, et al, et al
Sohnckestrasse 12
81479 München / DE
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
21.03.2013Invitation to proprietor to file observations on the notice of opposition
23.09.2013Reply of patent proprietor to notice(s) of opposition
12.12.2014Date of oral proceedings
27.01.2015Despatch of minutes of oral proceedings
27.01.2015Date of despatch of rejection of opposition
09.09.2019Legal effect of revocation of patent [2020/08]
19.12.2019Despatch of communication that the patent will be revoked
Appeal following opposition13.03.2015Appeal received No.  T0548/15
05.06.2015Statement of grounds filed
09.09.2019Result of appeal procedure: revocation of the patent
09.09.2019Date of oral proceedings
13.09.2019Minutes of the oral proceedings despatched
Fees paidRenewal fee
08.09.2010Renewal fee patent year 03
08.09.2010Renewal fee patent year 04
08.09.2010Renewal fee patent year 05
08.09.2010Renewal fee patent year 06
08.09.2010Renewal fee patent year 07
08.09.2010Renewal fee patent year 08
08.09.2010Renewal fee patent year 09
08.09.2010Renewal fee patent year 10
08.09.2010Renewal fee patent year 11
08.09.2010Renewal fee patent year 12
08.09.2010Renewal fee patent year 13
10.03.2011Renewal fee patent year 14
07.03.2012Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.05.2012
BE09.05.2012
DK09.05.2012
FI09.05.2012
IT09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
CH31.03.2013
LI31.03.2013
LU31.03.2013
MC31.03.2013
GB31.03.2015
IE31.03.2018
[2018/35]
Former [2016/07]AT09.05.2012
BE09.05.2012
DK09.05.2012
FI09.05.2012
IT09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
CH31.03.2013
LI31.03.2013
LU31.03.2013
MC31.03.2013
GB31.03.2015
Former [2015/34]AT09.05.2012
BE09.05.2012
DK09.05.2012
FI09.05.2012
IT09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
CH31.03.2013
LI31.03.2013
LU31.03.2013
MC31.03.2013
Former [2014/08]AT09.05.2012
BE09.05.2012
DK09.05.2012
FI09.05.2012
IT09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
CH31.03.2013
LI31.03.2013
MC31.03.2013
Former [2013/47]AT09.05.2012
BE09.05.2012
DK09.05.2012
FI09.05.2012
IT09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
MC31.03.2013
Former [2013/11]AT09.05.2012
BE09.05.2012
DK09.05.2012
FI09.05.2012
IT09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
Former [2013/08]AT09.05.2012
BE09.05.2012
DK09.05.2012
FI09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
Former [2013/07]AT09.05.2012
BE09.05.2012
FI09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
Former [2013/04]BE09.05.2012
FI09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
Former [2013/01]FI09.05.2012
SE09.05.2012
GR10.08.2012
PT10.09.2012
Former [2012/50]FI09.05.2012
SE09.05.2012
GR10.08.2012
Former [2012/48]FI09.05.2012
SE09.05.2012
Documents cited:Search[X]WO9211890  (MEDTRONIC INC [US]);
 [X]WO9416706  (NEORX CORP [US]);
 [X]WO9625176  (NEORX CORP [US], et al);
by applicantJPS471925B
 JPS4714219B
 JPS478533B
 JPS4723394B
 JPS471924B
 JPS474164B
 US4093709
 US4389330
 US4512762
 JPS61268687
 JPS62120388
 US4675189
 JPS62155284
 JPS62155285
 JPS62164626
 JPS62240689
 US4744981
 WO8807045
 JPS63295589
 JPS63295988
 EP0296110
 WO8810259
 US4824436
 US4835002
 JPH01143877
 JPH01149791
 EP0323171
 WO8907105
 JPH01246288
 US4879225
 JPH029819
 US4897255
 US4906452
 WO9001969
 WO9003768
 US4929602
 US4935415
 JPH02258724
 WO9013293
 EP0410389
 EP0411893
 JPH0372485
 US5015578
 WO9109034
 US5049132
 JPH03220194
 US5213576
 US5232444
 WO9317121
 US5282785
 WO9408604
 WO9408605
 US5328471
 WO9419000
 WO9419001
 WO9419003
 US5362424
 US5364632
 EP0639577
 US5407609
 WO9520582
 US5458568
 US5478860
 US19950389712
otherWO9745105
 US2010272773
 US2011015664
 DE102011100122
 US8439868
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.